Symptoms of anaphylaxis resolved in about nine out of 10 patients after one dose of neffy epinephrine spray, a new… Read more »
Author: Jenifer Goodwin
Can You Treat Shellfish and Fish Allergies? It’s Starting to Happen
In the U.S., nearly 3 percent of adults report a shellfish allergy. It is the most common food allergy in… Read more »
Scientists Elated as Drug Zileuton Stops Food Anaphylaxis in Mice
A decades-old asthma drug greatly reduced peanut allergen absorption into the bloodstream of peanut-allergic mice, protecting them from life-threatening anaphylaxis. … Read more »
Neffy Epinephrine Spray Rapidly Reversed Anaphylaxis in Children
Updated July 18, 2025: The nasal epinephrine sprayer neffy quickly reversed moderate anaphylaxis in children undergoing food allergy challenges, a… Read more »
What Allergy Patients Need to Know About First Xolair Biosimilar
The Food and Drug Administration has approved Omlyclo as a biosimilar for Xolair (omalizumab). Like Xolair, Omlyclo targets IgE antibodies… Read more »
FDA Reviewing Oral Epinephrine Film for Possible Approval
The Food and Drug Administration has accepted Aquestive Therapeutics’ new drug application for an oral epinephrine film to treat severe… Read more »
Ants With a Sting That Can Trigger Anaphylaxis Spread in U.S.
While swimming in her neighborhood pool, Stacey Vigil, a wildlife biologist, felt a sharp sting on her back. She swatted… Read more »
Neffy Maker Steps Up Awareness for MDs; Launches Kids’ Device
ARS Pharmaceuticals, the maker of neffy, is stepping up efforts to boost awareness of its needle-free epinephrine spray ahead of… Read more »
Is A Cure for Food Allergies Getting Close?
Ten years ago, Dr. James Baker, then chief medical officer of Food Allergy Research & Advocacy (FARE), told the organization… Read more »
Xolair Rival Aims for Food Allergy Dosing of Every 2 to 3 Months
Updated December 2025 – A San Francisco-based biotech company is developing a new blocker of the IgE allergy antibody for… Read more »